Open AccessGenetic variation in alcoholism and opioid addiction susceptibility and treatment: a pharmacogenomic approach
Author(s) -
Catherine Demery-Poulos,
Joseph M. Chambers
Publication year - 2021
Publication title -
aims molecular science
Language(s) - English
Resource type - Journals
eISSN - 2372-028X
pISSN - 2372-0301
DOI - 10.3934/molsci.2021016
Subject(s) - addiction , pharmacogenomics , opioid , genetic predisposition , alcohol dependence , psychology , polysubstance dependence , psychiatry , substance abuse , medicine , neuroscience , pharmacology , alcohol , gene , genetics , biology , biochemistry , receptor
Alcohol and opioid abuse have pervasive and detrimental consequences from the individual to societal level. The extent of genetic contribution to alcoholism has been studied for decades, yielding speculative and often inconsistent results since the previous discovery of two pharmacokinetic variants strongly protective against alcoholism. The neurobiology of addiction involves innumerate genes with combinatorial and epistatic interactions, creating a difficult landscape for concrete conclusions. In contrast, pharmacogenomic variation in the treatment of alcoholism yields more immediate clinical utility, while also emphasizing pathways crucial to the progression of addiction. An improved understanding of genetic predisposition to alcohol abuse has inherent significance for opioid addiction and treatment, as the two drugs induce the same reward pathway. This review outlines current knowledge, treatments, and research regarding genetic predisposition to alcoholism, focusing on pharmacodynamic variation within the dopaminergic system and shared implications for opioid abuse. Multifaceted and highly polygenic, the phenotype of addiction seems to grow more complex as new research extends the scope of its impact on the brain, body, and progeny.